4 Largecap Low Debt High Margin Five-Year Winner Stocks to Watch for Future Multibagger Potential: Sun Pharma, HAL, BSE and Indian Hotels

Low debt high margin five-year winner stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, HAL, BSE and Indian Hotels meet that test, with market caps from Rs 1.21 lakh crore to Rs 4.57 lakh crore and Sun Pharma offering the largest market cap at Rs 4,57,101 crore. Each of these companies has a debt to equity ratio below 0.3, an operating margin of at least 20 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a debt to equity ratio below 0.3, an operating margin of at least 20 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening low debt high margin five-year winner stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 11 November 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Low Debt High Margin Five-Year Winner Stocks and Why Do They Attract Multibagger Interest?

Low debt high margin five-year winner stocks are shares of large companies whose borrowing is small compared with shareholder funds, who keep at least twenty paise of operating profit from every rupee of sales and whose share price has at least doubled over five years. The four here cover pharmaceuticals, aerospace and defence, hotels and exchange services.

Low debt keeps the balance sheet safe, a rich margin shows pricing strength that does not depend on borrowed money, and a doubled share price shows that the market has rewarded the combination over a long period. Within low debt high margin five-year winner stocks, the four companies show rising profit. For low debt high margin five-year winner stocks, both FY26 and the latest quarter showed growth. Whichever way you read low debt high margin five-year winner stocks, the common thread is rising profit backed by complete financial data. A sensible way to study low debt high margin five-year winner stocks is to look at profit growth, returns and valuation side by side. Below, each of low debt high margin five-year winner stocks gets its own breakdown of growth, returns and valuation. Treat low debt high margin five-year winner stocks as a research list, since share prices and rankings change with every earnings season.

Low Debt High Margin Five-Year Winner Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 11 November 2026. HAL has the lowest PE of the group at 36.27, while BSE posts the highest return on equity at 37.42%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Sun Pharmaceutical Industries	1,902.30	4,57,101	37.72	36.42	13.74%	0.06	1,583.70 to 2,046.90
Hindustan Aeronautics	4,949	3,38,106	36.27	48.59	22.21%	0.00	3,479.10 to 5,149.90
BSE Ltd	3,906	1,67,274	59.28	42.42	37.42%	0.00	2,326.10 to 4,446.80
Indian Hotels Company	873	1,20,996	52.40	36.77	15.97%	0.22	568.70 to 971.00

Sun Pharma: 35.75% Profit CAGR Since FY22

Sun Pharmaceutical Industries is one of India's largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 111.23% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 37.72 against an industry PE of 36.42, with a return on equity of 13.74%.

HAL: Return on Equity of 22.21%

Hindustan Aeronautics is India's state-owned aerospace company that designs, makes and services fighter jets, helicopters, engines and avionics. It reported FY26 revenue of Rs 36,787.95 crore, up 9.68% year on year, and net profit of Rs 9,115.52 crore, up 8.98%. Net profit has compounded at 15.74% a year since FY22, while revenue has grown 9.48% a year. Operating margin was 40.89% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

The stock trades at a PE of 36.27 against an industry PE of 48.59, below the sector average, with a return on equity of 22.21%. In the June 2026 quarter, revenue rose 15.26% to Rs 6,415.41 crore and net profit grew 14.88% to Rs 1,589.66 crore. The share price has gained 624.91% over five years. Domestic institutions raised their holding from 8.71% in September 2025 to 12.56% in September 2026.

BSE: 78.30% Profit CAGR Since FY22

BSE Ltd operates one of India's two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026. The stock trades at a PE of 59.28 against an industry PE of 42.42, with a return on equity of 37.42%.

Indian Hotels: Quarterly Profit Up 22.39%

Indian Hotels Company, part of the Tata Group, runs Taj, SeleQtions, Vivanta and Ginger hotels and resorts. It reported FY26 revenue of Rs 9,971.43 crore, up 16.42% year on year, and net profit of Rs 2,195.14 crore, up 11.93%. Revenue has compounded at 32.74% a year since FY22. Operating margin was 35.53% in FY26. The debt-to-equity ratio is 0.22.

The stock trades at a PE of 52.40 against an industry PE of 36.77, with a return on equity of 15.97%. In the June 2026 quarter, revenue rose 15.09% to Rs 2,419.37 crore and net profit grew 22.39% to Rs 390.93 crore. The share price has gained 670.13% over five years. Domestic institutions raised their holding from 18.52% in June 2025 to 24.59% in June 2026.

Low Debt High Margin Five-Year Winner Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these low debt high margin five-year winner stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Sun Pharma	61,673.94	11,564.52	12.69%	11.62%	11.93%	32.52%
HAL	36,787.95	9,115.52	9.68%	9.48%	15.26%	44.22%
BSE	5,148.10	2,475.30	59.07%	56.26%	63.41%	77.03%
Indian Hotels	9,971.43	2,195.14	16.42%	32.74%	15.09%	32.19%

Check the Univest Screener for live data on these low debt high margin five-year winner stocks

Institutional Holding in Sun Pharma, HAL, BSE and Indian Hotels

Institutional holding shows who is backing these low debt high margin five-year winner stocks alongside the promoter. The table uses the latest reported quarter for each. Indian Hotels has the deepest institutional backing, with FII and DII together holding 46.30% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%), HAL (from 8.71% to 12.56%), BSE (from 13.51% to 24.15%) and Indian Hotels (from 18.52% to 24.59%). Keeping an eye on the Nifty 50 alongside this list shows whether these shares are moving with the wider market.

Stock	Promoter	FII	DII	Public	Quarter
Sun Pharma	52.68%	14.36%	22.27%	10.70%	September 2026
HAL	71.64%	9.42%	12.56%	6.38%	September 2026
BSE	Nil	21.32%	24.15%	54.53%	June 2026
Indian Hotels	38.12%	21.71%	24.59%	15.58%	June 2026

Risks to Weigh in Low Debt High Margin Five-Year Winner Stocks

Being careful with low debt high margin five-year winner stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Indian Hotels trades at a PE of 52.40 against an industry PE of 36.77, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Low Debt High Margin Five-Year Winner Stocks

Picking from low debt high margin five-year winner stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (36.42 to 48.59) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Sun Pharma, HAL, BSE and Indian Hotels live prices.

Conclusion

Among low debt high margin five-year winner stocks, Sun Pharma stands out for the largest market cap at Rs 4,57,101 crore, HAL for the lowest PE of the group at 36.27, BSE for the highest return on equity at 37.42% and Indian Hotels for 16.42% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing low debt high margin five-year winner stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Low Debt High Margin Five-Year Winner Stocks to Watch

Which are the best low debt high margin five-year winner stocks to watch for multibagger potential?

Ans. Sun Pharma, HAL, BSE and Indian Hotels are the 4 names this list highlights, with market caps of Rs 4,57,101 crore, Rs 3,38,106 crore, Rs 1,67,274 crore and Rs 1,20,996 crore respectively. Sun Pharma is notable for the largest market cap at Rs 4,57,101 crore. HAL stands out for the lowest PE of the group at 36.27. BSE offers the highest return on equity at 37.42%. Indian Hotels brings 16.42% revenue growth in FY26. These are watchlist names for low debt high margin five-year winner stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is BSE a good stock for long-term investors?

Ans. BSE has a return on equity of 37.42%, a PE of 59.28 against an industry PE of 42.42 and a market cap of Rs 1,67,274 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in low debt high margin five-year winner stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Sun Pharma become a multibagger from here?

Ans. Sun Pharma has already gained 111.23% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in low debt high margin five-year winner stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 37.72 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Sun Pharma, HAL, BSE and Indian Hotels?

Ans. As of 11 November 2026, Sun Pharma has a market cap of Rs 4,57,101 crore, HAL has a market cap of Rs 3,38,106 crore, BSE has a market cap of Rs 1,67,274 crore and Indian Hotels has a market cap of Rs 1,20,996 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on low debt high margin five-year winner stocks.

What are the risks of investing in low debt high margin five-year winner stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Indian Hotels trades at a PE of 52.40 against an industry PE of 36.77, so earnings growth needs to hold up.

Why is Indian Hotels trading at a PE of 52.40?

Ans. Indian Hotels' PE of 52.40 compares with an industry PE of 36.77. The market is paying a premium for a return on equity of 15.97%, latest-quarter profit growth of 22.39% and FY26 revenue growth of 16.42%, which also means the stock is more sensitive if growth slows. Investors in low debt high margin five-year winner stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Sun Pharma, HAL, BSE and Indian Hotels?

Ans. As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 21.98% of HAL (9.42% and 12.56%), 45.47% of BSE (21.32% and 24.15%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in low debt high margin five-year winner stocks, though it should be read with earnings trends rather than on its own.